Simulations Plus (NASDAQ:SLP) Sets New 12-Month Low - Time to Sell?

Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) shares hit a new 52-week low on Wednesday . The stock traded as low as $29.25 and last traded at $29.52, with a volume of 19129 shares trading hands. The stock had previously closed at $29.75.

Wall Street Analysts Forecast Growth

SLP has been the topic of several recent analyst reports. KeyCorp initiated coverage on Simulations Plus in a research report on Monday, July 29th. They set an "overweight" rating and a $47.00 target price on the stock. Craig Hallum reissued a "buy" rating and set a $56.00 target price on shares of Simulations Plus in a research report on Wednesday, July 3rd. BTIG Research decreased their price target on shares of Simulations Plus from $60.00 to $50.00 and set a "buy" rating for the company in a report on Thursday, October 24th. William Blair reissued an "outperform" rating on shares of Simulations Plus in a report on Thursday, October 24th. Finally, JMP Securities initiated coverage on Simulations Plus in a research report on Tuesday, July 16th. They set a "market perform" rating for the company. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $54.50.

Simulations Plus Stock Down 3.6 %

The company has a market cap of $573.89 million, a PE ratio of 58.53 and a beta of 0.69. The business has a 50-day simple moving average of $32.82 and a 200-day simple moving average of $40.27.

Simulations Plus (NASDAQ:SLP - Get Free Report) last posted its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.02. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The business had revenue of $18.70 million for the quarter, compared to the consensus estimate of $19.73 million. During the same period last year, the firm posted $0.18 earnings per share. The company's revenue was up 19.9% compared to the same quarter last year. On average, research analysts forecast that Simulations Plus, Inc. will post 1.14 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Walter S. Woltosz sold 20,000 shares of the company's stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $39.63, for a total transaction of $792,600.00. Following the completion of the sale, the director now owns 3,521,592 shares of the company's stock, valued at approximately $139,560,690.96. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have sold a total of 60,750 shares of company stock valued at $2,145,055 in the last 90 days. 20.90% of the stock is owned by insiders.

Institutional Investors Weigh In On Simulations Plus

Hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in Simulations Plus by 1.1% during the first quarter. Vanguard Group Inc. now owns 1,135,105 shares of the technology company's stock worth $46,710,000 after acquiring an additional 12,636 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Simulations Plus by 10.1% during the 2nd quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company's stock worth $20,128,000 after purchasing an additional 37,992 shares during the last quarter. Tributary Capital Management LLC raised its holdings in Simulations Plus by 54.7% in the 3rd quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company's stock valued at $10,425,000 after buying an additional 115,122 shares during the period. Kennedy Capital Management LLC raised its holdings in Simulations Plus by 3.2% in the 1st quarter. Kennedy Capital Management LLC now owns 229,439 shares of the technology company's stock valued at $9,441,000 after buying an additional 7,077 shares during the period. Finally, Bank of New York Mellon Corp lifted its position in Simulations Plus by 5.2% in the second quarter. Bank of New York Mellon Corp now owns 222,317 shares of the technology company's stock valued at $10,809,000 after buying an additional 11,048 shares during the last quarter. 78.08% of the stock is currently owned by institutional investors and hedge funds.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.